HCPLive Network

IDSA 2011: Dr. Christian Loucq on Successful Initial Results of a Malaria Vaccine Trial [Podcast]

BOSTON, MA—In this interview at the annual conference of the Infectious Diseases Society of America, Christian Loucq, MD, director of the PATH Malaria Vaccine Initiative, discusses promising initial results of a Phase III trial of the experimental malaria vaccine RTS,S.


Further Reading
A commonly asked question by physicians pertains to the ideal frequency of urine drug testing. The answer is an unequivocal “it depends”.
The federal government recently established a new strategic plan for Health Information Technology which is expected to be in effect until 2020.
The US Centers for Disease Control and Prevention (CDC) announced on Wednesday that workers in a lab in their Atlanta headquarters may have been exposed to a live strain of the Ebola virus.
More Reading
A commonly asked question by physicians pertains to the ideal frequency of urine drug testing. The answer is an unequivocal “it depends”.